Bridging Advanced Myeloma Patients to Subsequent Treatments and Clinical Trials with Classical Chemotherapy and Stem Cell Support

Researchers tested whether non-myeloablative chemotherapy with a stem cell boost provided disease control and hematopoietic improvement as a bridge to subsequent therapies.